Use of glutamine and low density lipoproteins isolated from egg yolk to improve buck semen freezing.
To improve the results obtained with a reference cryopreservation extender (control extender: Triladyl + 20% (v/v) egg yolk + 6.4% (v/v) glycerol) for freezing caprine semen, glutamine was added to 18 split ejaculates at concentrations of 0, 20, 40, 80 and 120 mM (experiment 1). In experiment 2, glutamine was added to 18 split ejaculates at concentrations of 20, 25, 30, 35 and 40 mM. In the third experiment, the egg yolk was replaced with the low-density lipoprotein (LDL) fraction of egg yolk. The quality of frozen then thawed spermatozoa in each extender was compared using computer-assisted semen analysis. In experiment 1, glutamine at concentrations of 20 mm and 40 mm significantly improved sperm motility compared with the control extender. However, at 120 mM, a significant decrease in motility and velocity was observed. In experiment 2, motility, curvilinear velocity and amplitude of lateral head displacement (ALH) were improved in glutamine at 25 mM compared with the control. In experiment 3, 8% LDL and 25 mM glutamine significantly improved sperm motility, straight line velocity and ALH. In the fourth experiment, the quality of the previously defined freezing extender (Triladyl + 8% (v/v) LDL + 25 mM glutamine + 6.4% (v/v) glycerol) was tested by comparing acrosome, tail membrane, plasma membrane and DNA integrity in 18 split ejaculates of frozen then thawed spermatozoa with spermatozoa that had been frozen then thawed in the control extender, and with spermatozoa from fresh, unfrozen sperm. The percentage of spermatozoa with intact acrosomes and tail membranes was significantly higher with the newly defined extender than that observed with the control extender. There was no significant difference in the percentage of spermatozoa with intact DNA between the frozen and fresh semen.
Al Ahmad
M Z Ali
MZ
UPSP DGER, Sanitary Risks and Biotechnology of Reproduction, National Veterinary School of Nantes, Nantes, France.
Chatagnon
G
G
Amirat-Briand
L
L
Moussa
M
M
Tainturier
D
D
Anton
M
M
Fieni
F
F
D000177:Acrosome / Q000187:drug effects / Q000502:physiology; D020101:Acrosome Reaction / Q000187:drug effects / Q000502:physiology; D000818:Animals; D015925:Cryopreservation / Q000379:methods / Q000662:veterinary*; D003451:Cryoprotective Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004530:Egg Yolk / Q000737:chemistry; D005973:Glutamine / Q000494:pharmacology*; D006041:Goats / Q000502:physiology; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008297:Male; D012661:Semen / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D012662:Semen Preservation / Q000379:methods / Q000662:veterinary*; D013081:Sperm Motility / Q000187:drug effects / Q000502:physiology; D013094:Spermatozoa / Q000187:drug effects / Q000502:physiology
D003451:Cryoprotective Agents; D008077:Lipoproteins, LDL; D005973:Glutamine